The Filings Report

Cardinal Health, Inc.

CAHNYSECIK 721371Healthcare / Healthcare Providers & Servicesfiscal year ends June71 quarters since 2008

Revenue, Q4 FY2026
—
no year-earlier figure
Net income
—
no year-earlier figure
Free cash flow
—
no year-earlier figure
Diluted EPS
—
not filed for a derived quarter
Revenue, TTM
—
trailing four quarters
Net margin, TTM
—
net income —
Free cash flow, TTM
—
Cash and equivalents
$4.9B
long-term debt —, Jun 30, 2026
Shares, 12-month change
−2.6%
233M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
$58.3B
at the close, buybacks

Latest quarter Q4 FY2026, filed August 11, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q4 FY2026, the quarter ended June 30, 2026, Cardinal Health, Inc. reported no revenue line.

The last 16 quarters

Q4 FY2022 to Q4 FY2026, through the filing of August 11, 2026.

Revenue and net incomeRevenueNet income
−$20B$0$20B$40B$60B$80BQ4'22, Revenue: $47.1BQ4'22, Net income: $133MQ4'22Q1'23, Revenue: $49.6BQ1'23, Net income: $98MQ1'23Q2'23, Revenue: $51.5BQ2'23, Net income: −$77MQ2'23Q3'23, Revenue: $50.5BQ3'23, Net income: $365MQ3'23Q4'23, Revenue: $53.4BQ4'23, Net income: $5MQ4'23Q1'24, Revenue: $54.6BQ1'24, Net income: −$12MQ1'24Q2'24, Revenue: $57.4BQ2'24, Net income: $368MQ2'24Q3'24, Revenue: $54.9BQ3'24, Net income: $261MQ3'24Q4'24, Revenue: $59.9BQ4'24, Net income: $235MQ4'24Q1'25, Revenue: $52.3BQ1'25, Net income: $416MQ1'25Q2'25, Revenue: $55.3BQ2'25, Net income: $400MQ2'25Q3'25, Revenue: $54.9BQ3'25, Net income: $506MQ3'25Q4'25, Revenue: $60.2BQ4'25, Net income: $239MQ4'25Q1'26, Revenue: $64.0BQ1'26, Net income: $450MQ1'26Q2'26, Revenue: $65.6BQ2'26, Net income: $467MQ2'26Q4'26−$20B$0$20B$40B$60B$80BQ4'22, Revenue: $47.1BQ4'22, Net income: $133MQ1'23, Revenue: $49.6BQ1'23, Net income: $98MQ1'23Q2'23, Revenue: $51.5BQ2'23, Net income: −$77MQ3'23, Revenue: $50.5BQ3'23, Net income: $365MQ3'23Q4'23, Revenue: $53.4BQ4'23, Net income: $5MQ1'24, Revenue: $54.6BQ1'24, Net income: −$12MQ1'24Q2'24, Revenue: $57.4BQ2'24, Net income: $368MQ3'24, Revenue: $54.9BQ3'24, Net income: $261MQ3'24Q4'24, Revenue: $59.9BQ4'24, Net income: $235MQ1'25, Revenue: $52.3BQ1'25, Net income: $416MQ1'25Q2'25, Revenue: $55.3BQ2'25, Net income: $400MQ3'25, Revenue: $54.9BQ3'25, Net income: $506MQ3'25Q4'25, Revenue: $60.2BQ4'25, Net income: $239MQ1'26, Revenue: $64.0BQ1'26, Net income: $450MQ1'26Q2'26, Revenue: $65.6BQ2'26, Net income: $467MQ4'26

Net income losses drawn in red.

Free cash flow
−$2B$0$2B$4BQ4'22, Free cash flow: $2.9BQ4'22Q1'23, Free cash flow: −$47MQ1'23Q2'23, Free cash flow: $512MQ2'23Q3'23, Free cash flow: $1.3BQ3'23Q4'23, Free cash flow: $646MQ4'23Q1'24, Free cash flow: $436MQ1'24Q2'24, Free cash flow: $1.1BQ2'24Q3'24, Free cash flow: −$139MQ3'24Q4'24, Free cash flow: $1.9BQ4'24Q1'25, Free cash flow: −$1.7BQ1'25Q2'25, Free cash flow: −$495MQ2'25Q3'25, Free cash flow: $2.8BQ3'25Q4'25, Free cash flow: $1.3BQ4'25Q1'26, Free cash flow: $865MQ1'26Q2'26, Free cash flow: $555MQ2'26Q4'26−$2B$0$2B$4BQ4'22, Free cash flow: $2.9BQ1'23, Free cash flow: −$47MQ1'23Q2'23, Free cash flow: $512MQ3'23, Free cash flow: $1.3BQ3'23Q4'23, Free cash flow: $646MQ1'24, Free cash flow: $436MQ1'24Q2'24, Free cash flow: $1.1BQ3'24, Free cash flow: −$139MQ3'24Q4'24, Free cash flow: $1.9BQ1'25, Free cash flow: −$1.7BQ1'25Q2'25, Free cash flow: −$495MQ3'25, Free cash flow: $2.8BQ3'25Q4'25, Free cash flow: $1.3BQ1'26, Free cash flow: $865MQ1'26Q2'26, Free cash flow: $555MQ4'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ4'22, Cash and equivalents: $4.7BQ4'22Q1'23, Cash and equivalents: $3.5BQ1'23Q2'23, Cash and equivalents: $3.7BQ2'23Q3'23, Cash and equivalents: $4.0BQ3'23Q4'23, Cash and equivalents: $4.1BQ4'23Q1'24, Cash and equivalents: $3.9BQ1'24Q2'24, Cash and equivalents: $4.6BQ2'24Q3'24, Cash and equivalents: $3.7BQ3'24Q4'24, Cash and equivalents: $5.1BQ4'24Q1'25, Cash and equivalents: $2.9BQ1'25Q2'25, Cash and equivalents: $3.8BQ2'25Q3'25, Cash and equivalents: $3.3BQ3'25Q4'25, Cash and equivalents: $3.9BQ4'25Q1'26, Cash and equivalents: $4.6BQ1'26Q2'26, Cash and equivalents: $2.8BQ2'26Q4'26, Cash and equivalents: $4.9BQ4'26$0$2B$4B$6BQ4'22, Cash and equivalents: $4.7BQ1'23, Cash and equivalents: $3.5BQ1'23Q2'23, Cash and equivalents: $3.7BQ3'23, Cash and equivalents: $4.0BQ3'23Q4'23, Cash and equivalents: $4.1BQ1'24, Cash and equivalents: $3.9BQ1'24Q2'24, Cash and equivalents: $4.6BQ3'24, Cash and equivalents: $3.7BQ3'24Q4'24, Cash and equivalents: $5.1BQ1'25, Cash and equivalents: $2.9BQ1'25Q2'25, Cash and equivalents: $3.8BQ3'25, Cash and equivalents: $3.3BQ3'25Q4'25, Cash and equivalents: $3.9BQ1'26, Cash and equivalents: $4.6BQ1'26Q2'26, Cash and equivalents: $2.8BQ4'26, Cash and equivalents: $4.9BQ4'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q4 FY2026 filed August 11, 2026.

Cardinal Health, Inc. income statement, quarterly
Millions of dollarsQ4 FY2026ended Jun 30, 2026filed Aug 11, 2026Q2 FY2026ended Dec 31, 2025filed Feb 5, 2026Q1 FY2026ended Sep 30, 2025filed Oct 30, 2025Q4 FY2025ended Jun 30, 2025filed Aug 12, 2025Q3 FY2025ended Mar 31, 2025filed May 1, 2025Q2 FY2025ended Dec 31, 2024filed Jan 30, 2025Q1 FY2025ended Sep 30, 2024filed Nov 1, 2024Q4 FY2024ended Jun 30, 2024filed Aug 14, 2024YoYQ4 FY2026vs Q4 FY2025
Revenue—65,62764,00960,15954,87855,26452,27759,867—
Cost of revenue—63,23061,69057,95752,75553,32350,37557,985—
Gross profit—2,3972,3192,2022,1231,9411,9021,882—
Research and development—————————
Selling, general and administrative—1,5041,4611,4841,3151,3061,2771,277—
Operating income—707668428730549568401—
Other income (expense)—1110309(3)5(1)—
Pretax income—630598384665511541391—
Income tax—159144141157110124158—
Net income—467450239506400416235—
Diluted EPS ($)——1.88———1.70——
Diluted shares (millions)—237239—241243245——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q4 FY2026 filed August 11, 2026.

Cardinal Health, Inc. balance sheet, quarterly
Millions of dollarsQ4 FY2026ended Jun 30, 2026filed Aug 11, 2026Q2 FY2026ended Dec 31, 2025filed Feb 5, 2026Q1 FY2026ended Sep 30, 2025filed Oct 30, 2025Q4 FY2025ended Jun 30, 2025filed Aug 12, 2025Q3 FY2025ended Mar 31, 2025filed May 1, 2025Q2 FY2025ended Dec 31, 2024filed Jan 30, 2025Q1 FY2025ended Sep 30, 2024filed Nov 1, 2024Q4 FY2024ended Jun 30, 2024filed Aug 14, 2024YoYQ4 FY2026vs Q4 FY2025
Cash and equivalents4,8562,7774,5933,8743,3263,8102,8675,133+25.3%
Short-term investments———————200—
Total current assets38,75339,23038,53736,37334,59535,75632,90534,884+6.5%
Total assets57,29958,08355,22853,12249,87147,00243,05945,121+7.9%
Total current liabilities43,90443,31440,26838,89736,66235,22334,67835,640+12.9%
Long-term debt—————————
Total liabilities—————————
Stockholders’ equity(2,883)(2,884)(2,879)(2,781)(2,948)(2,991)(3,277)(3,213)−3.7%
Shares outstanding (millions)233235238239239242242244—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q4 FY2026 filed August 11, 2026.

Cardinal Health, Inc. cash flow statement, quarterly
Millions of dollarsQ4 FY2026ended Jun 30, 2026filed Aug 11, 2026Q2 FY2026ended Dec 31, 2025filed Feb 5, 2026Q1 FY2026ended Sep 30, 2025filed Oct 30, 2025Q4 FY2025ended Jun 30, 2025filed Aug 12, 2025Q3 FY2025ended Mar 31, 2025filed May 1, 2025Q2 FY2025ended Dec 31, 2024filed Jan 30, 2025Q1 FY2025ended Sep 30, 2024filed Nov 1, 2024Q4 FY2024ended Jun 30, 2024filed Aug 14, 2024YoYQ4 FY2026vs Q4 FY2025
Operating cash flow—6869731,5272,913(396)(1,647)2,082—
Capital expenditures—1311082321269990193—
Free cash flow (CFO − capex)—5558651,2952,787(495)(1,737)1,889—
Depreciation and amortization—234233209207192182186—
Share repurchases—3833750375153750—
Dividends paid—122129120124122128122—

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2026 filed August 11, 2026.

Income statement

Cardinal Health, Inc. income statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 11, 2026FY2025ended Jun 30, 2025filed Aug 12, 2025FY2024ended Jun 30, 2024filed Aug 14, 2024FY2023ended Jun 30, 2023filed Aug 15, 2023FY2022ended Jun 30, 2022filed Aug 11, 2022FY2021ended Jun 30, 2021filed Aug 16, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 30, 2018filed Aug 22, 2018FY2017ended Jun 30, 2017filed Aug 10, 2017FY2016ended Jun 30, 2016filed Aug 12, 2016FY2015ended Jun 30, 2015filed Aug 13, 2015FY2014ended Jun 30, 2014filed Aug 13, 2014FY2013ended Jun 30, 2013filed Aug 20, 2013FY2012ended Jun 30, 2012filed Aug 22, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Sep 2, 2010FY2009ended Jun 30, 2009filed Nov 9, 2009FY2008ended Jun 30, 2008filed Nov 9, 2009
Revenue254,248222,578226,827204,979181,326162,467152,922145,534136,809129,976121,546102,53191,084101,093107,552102,64498,50395,99287,408
Cost of revenue244,474214,410219,413198,105174,842155,689146,054138,700129,628123,432115,003————————
Gross profit9,7748,1687,4146,8746,4846,7786,8686,8347,1816,5446,5435,7125,1614,9214,5414,1623,7813,7483,777
Research and development———————————————————
Selling, general and administrative6,1325,3825,0004,8004,5124,5334,5724,4804,5963,7753,6483,2403,0282,8752,6772,5282,3972,3342,341
Operating income2,6132,2751,243752(607)472(4,098)2,0601262,1202,4592,1611,8859961,7921,5141,3071,2871,392
Other income (expense)31419(5)(22)471(15)(23)5(5)7461512213(13)39
Pretax income2,1742,1011,201663(784)323(3,772)1,751(228)1,9242,2761,9671,7988881,6981,5181,2121,1601,295
Income tax469532348332153(289)(79)386(487)630845755635553628552625402448
Net income1,7141,561852330(938)611(3,696)1,3632561,2881,4271,2151,1663341,0699596421,1521,301
Diluted EPS ($)7.236.453.451.26(3.37)2.08(12.61)4.530.814.034.323.623.380.973.062.721.773.18—
Diluted shares (millions)237242247262279294293301315320330335345344349353361362364

Balance sheet

Cardinal Health, Inc. balance sheet, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 11, 2026FY2025ended Jun 30, 2025filed Aug 12, 2025FY2024ended Jun 30, 2024filed Aug 14, 2024FY2023ended Jun 30, 2023filed Aug 15, 2023FY2022ended Jun 30, 2022filed Aug 11, 2022FY2021ended Jun 30, 2021filed Aug 16, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 30, 2018filed Aug 22, 2018FY2017ended Jun 30, 2017filed Aug 10, 2017FY2016ended Jun 30, 2016filed Aug 12, 2016FY2015ended Jun 30, 2015filed Aug 13, 2015FY2014ended Jun 30, 2014filed Aug 13, 2014FY2013ended Jun 30, 2013filed Aug 20, 2013FY2012ended Jun 30, 2012filed Aug 22, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Sep 2, 2010FY2009ended Jun 30, 2009filed Nov 9, 2009FY2008ended Jun 30, 2008filed Nov 9, 2009
Cash and equivalents4,8563,8745,1334,0764,7173,4072,7712,5311,7636,8792,3564,6162,8651,9012,2741,9292,7551,221809
Short-term investments——200————————————————
Total current assets38,75336,37334,88433,73732,93531,04825,94025,74724,55328,34521,95621,75217,93917,77017,51016,31614,91920,982—
Total assets57,29953,12245,12143,34943,87844,45340,76640,96339,95140,11234,12230,14226,03325,81924,26022,84619,99025,119—
Total current liabilities43,90438,89735,64033,74030,55027,62423,61524,10922,89321,22119,70117,24315,11514,59014,17413,37011,53812,275—
Long-term debt———————————————2,5022,1293,638—
Total liabilities———————————————————
Stockholders’ equity(2,883)(2,781)(3,213)(2,958)(709)1,7911,7896,3286,0596,8086,5546,2566,4015,9756,2445,8495,2768,7257,748
Shares outstanding (millions)233239244251273290292298309316319327337339341345———

Cash flow statement

Cardinal Health, Inc. cash flow statement, annual
Millions of dollarsFY2026ended Jun 30, 2026filed Aug 11, 2026FY2025ended Jun 30, 2025filed Aug 12, 2025FY2024ended Jun 30, 2024filed Aug 14, 2024FY2023ended Jun 30, 2023filed Aug 15, 2023FY2022ended Jun 30, 2022filed Aug 11, 2022FY2021ended Jun 30, 2021filed Aug 16, 2021FY2020ended Jun 30, 2020filed Aug 13, 2020FY2019ended Jun 30, 2019filed Aug 20, 2019FY2018ended Jun 30, 2018filed Aug 22, 2018FY2017ended Jun 30, 2017filed Aug 10, 2017FY2016ended Jun 30, 2016filed Aug 12, 2016FY2015ended Jun 30, 2015filed Aug 13, 2015FY2014ended Jun 30, 2014filed Aug 13, 2014FY2013ended Jun 30, 2013filed Aug 20, 2013FY2012ended Jun 30, 2012filed Aug 22, 2012FY2011ended Jun 30, 2011filed Aug 26, 2011FY2010ended Jun 30, 2010filed Sep 2, 2010FY2009ended Jun 30, 2009filed Nov 9, 2009FY2008ended Jun 30, 2008filed Nov 9, 2009
Operating cash flow5,1742,3973,7622,8443,1752,4291,9602,7222,7681,1842,9712,5402,5241,7271,1761,3952,1341,4241,542
Capital expenditures649547511481387400375328384387465300249195260291260421—
Free cash flow (CFO − capex)4,5251,8503,2512,3632,7882,0291,5852,3942,3847972,5062,2402,2751,5329161,1041,8741,003—
Depreciation and amortization9567907106926927839131,0001,032717641451459397325313254226220
Share repurchases1,3587657502,0001,0002003506005506006511,03667345045027023001,182
Dividends paid491494499525559573569577581577512460415353300274253200173

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$60M
31 sales by 7 insiders; officers and directors $60M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$62M
35 sales by 8 insiders; officers and directors $62M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Aug 19, 2026Scherer Mary C.Chief Accounting Officeropen-market sale100$237.40$24K5,013Aug 20, 2026
Aug 19, 2026Scherer Mary C.Chief Accounting Officeropen-market sale2,202$237.39$523K2,811Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale6,206$233.22$1M228,926Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale3,457$234.29$810K225,469Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale5,704$235.34$1M219,765Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale6,731$236.46$2M213,034Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale16,187$237.23$4M196,847Aug 20, 2026
Aug 19, 2026Hollar Jason M.Chief Executive Officeropen-market sale6,244$237.88$1M190,603Aug 20, 2026
Aug 18, 2026Hollar Jason M.Chief Executive Officeropen-market sale21,407$234.56$5M293,725Aug 20, 2026
Aug 18, 2026Hollar Jason M.Chief Executive Officeropen-market sale29,915$235.51$7M263,810Aug 20, 2026
Aug 18, 2026Hollar Jason M.Chief Executive Officeropen-market sale16,208$236.54$4M247,602Aug 20, 2026
Aug 18, 2026Hollar Jason M.Chief Executive Officeropen-market sale12,470$237.25$3M235,132Aug 20, 2026
Aug 18, 2026Mason Stephen MCEO, GMPD Segmentopen-market sale3,100$234.59$727K49,961Aug 20, 2026
Aug 18, 2026Mason Stephen MCEO, GMPD Segmentopen-market sale8,195$235.62$2M41,766Aug 20, 2026
Aug 18, 2026Mason Stephen MCEO, GMPD Segmentopen-market sale10,876$236.50$3M30,890Aug 20, 2026
Aug 18, 2026Mason Stephen MCEO, GMPD Segmentopen-market sale12,829$237.26$3M18,061Aug 20, 2026
Aug 18, 2026Weitzman DeborahCEO, PSS Segmentopen-market sale6,665$235.30$2M78,590Aug 20, 2026
Aug 18, 2026Weitzman DeborahCEO, PSS Segmentopen-market sale408$236.59$97K78,182Aug 20, 2026
Aug 18, 2026Weitzman DeborahCEO, PSS Segmentopen-market sale281$237.44$67K77,901Aug 20, 2026
Aug 18, 2026Alt Aaron EChief Financial Officeropen-market sale3,115$234.55$731K59,380Aug 20, 2026
Aug 18, 2026Alt Aaron EChief Financial Officeropen-market sale12,228$235.54$3M47,152Aug 20, 2026
Aug 18, 2026Alt Aaron EChief Financial Officeropen-market sale13,685$236.58$3M33,467Aug 20, 2026
Aug 18, 2026Alt Aaron EChief Financial Officeropen-market sale12,972$237.26$3M20,495Aug 20, 2026
Aug 18, 2026Mayer Jessica LChief Legal/Compliance Officeropen-market sale3,900$234.64$915K58,612Aug 20, 2026
Aug 18, 2026Mayer Jessica LChief Legal/Compliance Officeropen-market sale10,246$235.51$2M48,366Aug 20, 2026

Full insider history for Cardinal Health, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 6; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Cardinal Health, Inc., CIK 721371 on EDGAR
Extract generated
October 6, 2026
Withheld
none
Repaired
3 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2009, operating income FY2018, income tax FY2020
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated October 6, 2026.

JSON file
/data/financials/CAH.json